ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1713

Prevention of Arthritis Development by Mechanical Unloading Through Inhibition of CCL2 and YAP-mediated Inflammation in the Rat Adjuvant-induced Arthritis Model

Elisa Dalix1, Mathieu Maalouf1, Robin Caire2, Guillaume Courbon1, Virginie Dumas3, Sylvie Peyroche1, Marie-Thérèse Linossier1, Mireille Thomas1, Charles-Antoine Arthaud1, Arnaud Vanden-Bossche1 and Hubert Marotte4, 1Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, Saint-Etienne, France, 2Department of Molecular Medicine, University of Padua School of Medicine, Padua, Italy, 3Laboratory of Tribology and Systems Dynamics, Ecole Nationale d'Ingénieurs de Saint Etienne, Ecole Centrale de Lyon, University of Lyon, Saint-Etienne, France, 4CHU Saint-Etienne, Saint-Etienne, France

Meeting: ACR Convergence 2023

Keywords: Inflammation, physical activity, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1713–1733) RA – Animal Models Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is the most common chronic inflammatory rheumatic disease, characterized by synovitis associated with progressive bone loss and joint degradation. The adjuvant-induced arthritis (AIA) model mimics the pathophysiological features of RA, with high prevalence and reproducibility. Yes-associated protein (YAP) is a transcription factor involved in inflammatory signaling and arthritis progression, especially by driving the RA fibroblast-like synoviocyte (FLS) phenotype. Beyond inflammation sensing, YAP responds to mechanical stimuli. The inhibition of YAP transcriptional activity decreases arthritis in the AIA model. The objective of this study was then to investigate the effect of mechanical loading or unloading on arthritis.

Methods: For in vitro studies, a compressive dynamic pressure (100mmHg) was applied on RA FLS organoids. For in vivo studies, mechanical loading (voluntary running), unloading (tail suspension) or no mechanical stress (control) was applied in AIA rats (n=11/group), from arthritis induction (day[D]0) until D17. Running rats only ran (1.5km/day) from D0 to D10, which is the arthritis onset in the AIA model. Daily clinical monitoring was assessed to follow the severity of arthritis. In vivo µ-computed tomography was realized to follow arthritis-induced bone loss.At D10 or D17, the ankles of the rats were collected to perform RT-qPCR. At D17, blood samples were collected to perform protein dosages.

Results: In RA organoids, mechanical stress was able to induce inflammation by increasing IL6 and CCL2 expression (Figure 1). Surprisingly, YAP transcriptional activity remained unchanged in response to mechanical stress in RA organoids. In AIA rats, CCL2 expression is increased before arthritis onset, but also during and after the peak of inflammation (D17), independently from YAP activity. In AIA rats, the control and running groups displayed the same disease onset (D10) and progression, with similar arthritis index and ankle circumference over time (Figure 2). No difference in expression of bone degradation markers (RANK ligand, Cathepsin K, MMP9, and MMP13) was observed in joint at D17 between the control and running groups (Figure 2) and pro-inflammatory mediators (IL6, IL1B, TNF, and CCL2) (Figure 3). However, the expression of pro-inflammatory mediators and bone degradation markers trended to increase in the running AIA rats joint at D10. The suspension prevented arthritis development with a decreased expression of bone degradation markers (Figure 2) and pro-inflammatory mediators in the joint at D17 (Figure 3). Moreover, arthritis-induced bone loss was inhibited in the suspension group, where cortical porosity and trabecular volume remained similar to baseline.YAP transcriptional activity also trended to decrease.

Conclusion: In conclusion, two independent mechanisms could be involved in arthritis in response to mechanical stress, one mediated by YAP and the other involving CCL2. Mechanical unloading might then prevent arthritis by decreasing YAP activity and CCL2 production. A high level of CCL2 might then increase arthritis severity by inducing inflammation at arthritis onset, leading to an increase in YAP activity and joint degradation.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: E. Dalix: None; M. Maalouf: None; R. Caire: None; G. Courbon: None; V. Dumas: None; S. Peyroche: None; M. Linossier: None; M. Thomas: None; C. Arthaud: None; A. Vanden-Bossche: None; H. Marotte: None.

To cite this abstract in AMA style:

Dalix E, Maalouf M, Caire R, Courbon G, Dumas V, Peyroche S, Linossier M, Thomas M, Arthaud C, Vanden-Bossche A, Marotte H. Prevention of Arthritis Development by Mechanical Unloading Through Inhibition of CCL2 and YAP-mediated Inflammation in the Rat Adjuvant-induced Arthritis Model [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/prevention-of-arthritis-development-by-mechanical-unloading-through-inhibition-of-ccl2-and-yap-mediated-inflammation-in-the-rat-adjuvant-induced-arthritis-model/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevention-of-arthritis-development-by-mechanical-unloading-through-inhibition-of-ccl2-and-yap-mediated-inflammation-in-the-rat-adjuvant-induced-arthritis-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology